- LyondellBasell expands its Purell portfolio in North America as of October 1, 2025.
- Purell polymers are used in medical applications like syringes and IV bottles.
- The expansion includes regulatory compliance with USP and EU Pharmacopeia.
- Customers receive a two-year notification of change for supply predictability.
Expansion Announcement
On October 1, 2025, LyondellBasell announced the expansion of its Purell healthcare polymers portfolio in North America. This move aims to bring their established service model and innovation-driven products closer to North American customers.
Applications and Benefits
The Purell portfolio is designed for various medical and healthcare applications, including syringes, ampoules, IV bottles, diagnostic housings, labware, inhalers, and packaging. Customers benefit from stringent quality and traceability systems, dedicated manufacturing and logistics protocols, and regulatory readiness, including compliance with USP and EU Pharmacopeia standards.
Supply Predictability
One of the key features of the Purell portfolio is the two-year notification of change (NOC), which provides unmatched supply predictability for customers, ensuring they can plan and innovate with confidence.
Industry Insights
Natalie Nichols, Sr. Director of Specialties & Performance Products, emphasized the importance of meeting the performance demands of the healthcare industry. Simon Foster, industry marketing manager for healthcare, highlighted the significance of understanding the unique pressures of the healthcare sector and the value of local support and collaboration.
